Role Chitosan Film as a Catalyst for Rapid Gingival Healing:
An Innovation in Periodontal Therapy
Basri A. Gani1*, Subhaini Jakfar2, Pitu Wulandari3, Fitri Yunita Batubara4, Kemala Hayati5
Rike Rayanti6, Jeti Erawati7, Viona Diansari2
1Department of Oral Biology, Dentistry Faculty,
Universitas Syiah Kuala, Darussalam, Banda Aceh, Aceh, Indonesia.
2Department of Dental Material, Dentistry Faculty,
Universitas Syiah Kuala, Darussalam, Banda Aceh, Aceh, Indonesia.
3Department of Periodontics, Dentistry Faculty, Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia.
4Department of Conservative Dentistry, Dentistry Faculty,
Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia.
5Department of Oral Radiology, Dentistry Faculty, Universitas Syiah Kuala, Darussalam, Banda Aceh, Indonesia
6Department Dentistry, Hospital of Bhayangkara Mobile Brigade, Indonesian National Police, Depok, Indonesia.
7Department of Periodontics, Dentistry Faculty, Universitas Trisakti, Jakarta, Indonesia.
*Corresponding Author E-mail: basriunoe@usk.ac.id
ABSTRACT:
Healing of gingival wounds after periodontal surgery is a crucial aspect that influences the success of the procedure and patient comfort.Chitosan films, with their biocompatibility and biodegradability properties, have been explored as a drug delivery medium to accelerate tissue regeneration.This study aims to evaluate the effectiveness of chitosan film as a stimulant for gingival wound healing by increasing local drug delivery. Blood smear preparations assessed the immune cells, andHematoxylin and Eosin staining evaluated the number of fibroblast cells, osteoblast cells, and osteoclasts.Meanwhile, the Il-1β titers were assessed using the ELISA assay.Film chitosan 30% has a good effect on maintaining immune cell responses, increasing the number of fibroblast cells, preventing gingival epithelial cell toxicity, increasing osteoblast cell function, and reducing alveolar bone osteoclasts.In addition, Its film 30% can reduce the response of IL-1β and post-gingival trauma.This study proves that chitosan film as a drug delivery agent can catalyze periodontal therapy, accelerating gingival healing.Thus, chitosan films offer a promising, innovative therapeutic strategy for application in periodontal surgery.
KEYWORDS: Chitosan Film, Gingival Wound Healing, Drug Delivery, Periodontal Therapy, Tissue Regeneration.
INTRODUCTION:
Gingival trauma is a common oral health problem caused by various factors, such as mechanical injury, periodontal disease, or dental procedures. Effective treatment and rapid healing of gingival trauma are essential to prevent complications and ensure optimal oral health1.
Following a gingivectomy procedure, various aspects manifest, including heightened bleeding, infection, pain and discomfort, reoccurrence of periodontal disease, hypersensitivity, diminished gum recession, aesthetic concerns, and potential patient discontent2. In the biological aspect of healing, the spread of infection and hypersensitivity are the factors most considered because they relate to the degree of recovery3. Secondary infections emergefrom postoperative treatment and protective factors against surgical wounds4. Using a periodontal pack on the traumatized gingiva and protecting against infection also helps accelerate wound healing5. However, there have also been reports of functional failure of the periodontal pack covering the surgical wound, causing an increase in infection and re-treatment6. It also slows wound healing, interfering with patient comfort after periodontal surgery.
This problem is still being discussed now after periodontal surgery. Many researchers continue developing strategies, including using antibiotics and painkillers to prevent and enhance healing responses. However, this effort triggers a new problem:Antibiotics tend to affect the balance of commensal bacteria in the oral cavity7. It can even increase the occurrence of hypersensitivity to the gum tissue8. Films derived from natural materials continue to be developed as a wound cover after surgery and as a drug delivery to maintain tissue and cell proliferation until healing occurs9. There is increasing interest in applying innovative approaches, such as chitosan, to improve the healing process in oral tissues10.
Chitosan plays an essential role in wound healing through various synergistic mechanisms.Its hemostatic properties help stop bleeding quickly, a crucial first step in wound care11. Furthermore, chitosan utilizes its positive charge to disrupt bacterial membranes, reducing the risk of infection with its antibacterial properties.It keeps the wound environment clean and conducive to healing12. Chitosan also promotes cellular activity by supporting fibroblast adhesion and proliferation, which is essential for synthesizing extracellular matrix and collagen, which are vital components in tissue regeneration13. In addition, chitosan’s ability to regulate wound moisture supports creating an optimal moist environment for an efficient healing process.The advantages of chitosan are not only limited to its intrinsic properties but also its ability to act as a carrier for drugs or growth factors that can accelerate wound healing14. Its biodegradability allows chitosan to integrate with tissue without causing significant side effects, eliminating the need for material removal and minimizing disruption to the healing area15.
Chitosan has been developed by Gani (2023) in the form of films for application to wounds16. As the leadingfilm component, chitosan has properties that positively influence the healing process17. In theory, chitosan, in forming a film, can function as a barrier to infectious agents and protect cells and tissue in the wound area15. The chitosan film creates a microenvironment that isolates the surgical wound from bacteria and external debris, reduces the risk of infection, and allows healing cells, such as epithelial and fibroblast cells, to develop without interference18. In addition, chitosan is also known to stimulate fibroblast cell proliferation and extracellular matrix synthesis, which supports better tissue formation19. This study aims to evaluate the effectiveness of chitosan film as a stimulant for gingival wound healing by increasing local drug delivery.
Material and Methods:
Ethical considerations:
This research has passed ethical clearance No 341/KE/FKG/2022 from the Faculty of Dentistry, Syiah Kuala University, Darussalam, Banda Aceh, Indonesia.The research material comprised 25 model animals (Rattus novergicus) divided into five groups.Each treatment group was given the same treatment before Gingival trauma. It also uses a film chitosan, which was made in the Chemistry Laboratory, Faculty of Teacher Training and Education, Syiah Kuala University, Banda Aceh, Indonesia.
Animal Model of Gingiva Trauma:
This study used Rattus novergicus aged 8-10 weeks with a body weight of 150-200 grams.Before treatment, mice were acclimatized for seven days in a conductive atmosphere (temperature, water, food, light-dark cycle, and noise).Treatment of the gingival trauma model begins with anesthesia Ketamine base 100mg/Kg Body Weight and Xylazine 5mg/Kg Body Weight, intramuscularly20. Start by determining the bleeding point with a pocket marker for gingival trauma. Then, incisions were made on the facial and lingual/palatal parts using a Kirkland knife number 12 and 15, while on the proximal portion using an Orban knife.The incision is made apical to the bleeding point at an angle of 45 to the coronal direction. Then, gingival trauma is performed, and a film is applied to the incision area and covered with a periodontal pack at the incision area. Then, a microscopic examination of fibroblast cells, epithelial cells, toxic cells, osteoblast cells, and alveolar bone osteoclasts was carried out.
Immune Cell Assay:
Examination of blood immune cells from animal models of gingival trauma using a thin smear blood preparation approach based on the working principles of Adewoyin (2014)21. In the first stage, a glass object with a drop of blood is placed on a table or flat surface. Then, attach the object glass by pressing your left index finger on the end of the glass without the identification sticker. Then, another glass object is prepared, which functions as a pusher. Next, the glass pusher is placed on top of the second drop of blood at a 45oC angle. Then, let the blood spread to all ends of the glass object. Then, the pushing glass object is pulled back about 5mm and moved forward while maintaining an angle of 45 degrees.Then, the smear was allowed to dry at room temperature after being soaked in 76% methanol for 30 minutes, given 3% Giemsa solution for 30 minutes, washed with running water, placed on its side, and allowed to dry. Further observations were carried out under a microscope with 400x magnification.
Fibroblast Assessment:
ELISA Assay:
Assessment of IL-1β Assay using Elisa kits from Elabscience Biotechnology Inc, Texas, USA).The protein titers were assessed, and 96 well plates labeled with antibodies were added to the standard solution and sample (gingival tissue supernatant), each 100μL (Duplo).Then, it was covered with a sealing plate and incubated for 90 min at 37°C.Then, the liquid was removed, and 100µL of Biotinylated Detection Ab solution was added to each well and covered with a plate sealer.Then resuspended and incubated for 60min at 37°C.Then, washed with 350µL of washing buffer into each well for 1-2min and aspirated and patted on absorbent paper until the wells were dry. They were washing steps three times.Then, 100µL of conjugated HRP concentrate solution was added to each well, covered with a plate sealer, and then incubated for 30 mins at 37°C. Then, aspirated and washed with wash buffer three times.Then 90µL of substrate reagent was added to each well, covered with a plate sealer, and incubated for about 15 min at 37°C. Then, 50µL Stop solution was added to each well and read at a wavelength of 450nm.
Statistical Analysis:
Differences in the quantity and quality of the number of immune cells, fibroblast cells, and titer of IL-1β were analyzed using One-way ANOVA, with a significance limit of p<0.05.(IBM SPSS Statistics 23.0).
Result and Discussion:
Chitosan films containing antioxidants can be crucial in healing surgical wounds. Antioxidants help protect body tissue from damage caused by excessive oxidative reactions, which can occur during inflammation, injury, or wound healing.When healing surgical wounds, chitosan films with antioxidants can protect against oxidative stress, reduce inflammation, stimulate tissue regeneration, prevent infection, increase angiogenesis, and reduce scar tissue formation23. Chitosan and Moringa leaves, besides containing high levels of antioxidants, also have anti-inflammatory compounds. This property is reported to play a role in maintaining the stability of the immune response and preventing tissue toxicity due to the ROS response when infection occurs24. These results indicate that films used for therapy in gingival surgery can be used as antioxidants to improve postoperative healing because antioxidants help reduce cell damage caused by unstable molecules called free radicals25.
Table 1 reports that the chitosan film provides a good immunotolerance response in increasing healing after gingival trauma. Films can reduce inflammatory cell response and promote healing (Fig 1). While the negative control shows inflammatory cells above standard limits, meaning an infection response is still occurring.Even though treatment for seven days has not demonstrated complete healing in the gingival area, it was indicated that Eusionophil cells were still found to suggest that the allergic response process was still ongoing.However, these films generally help improve wound healing in post-periodontal surgery gingival trauma models.
Figure 1. Representative immune cells exposed during the gingival healing process after periodontal surgery treated with 30% film.(A) Neutrophils, (B) Basophils, (C) Lymphocytes, (D) Eusinophils, and (E) Monocytes.400x magnification
Table 1. Response of blood immune cells of post gingiva trauma
|
Chitosan Film |
N |
Inflammatory cells (%) 7 days |
*p-Value |
||||||||||||||||||
|
Neutrophils |
Basophils |
Lymphocytes |
Eosinophils |
Monocytes |
|||||||||||||||||
|
SD |
Amount |
SD |
Amount |
SD |
Amount |
SD |
Amount |
SD |
Amount |
||||||||||||
|
CF10% |
5 |
0.58 |
45 |
1.37 |
3 |
1.27 |
42 |
1.73 |
2 |
0.23 |
11 |
0.001 |
|||||||||
|
CF20% |
5 |
1.73 |
47 |
0.52 |
3 |
1.35 |
37 |
1.21 |
2 |
1.47 |
10 |
||||||||||
|
CF30% |
5 |
1.15 |
35 |
0.12 |
1 |
0.26 |
26 |
1.36 |
2 |
1.01 |
8 |
||||||||||
|
CF |
5 |
1.23 |
52 |
2.45 |
4 |
0.11 |
46 |
3.11 |
2 |
2.87 |
11 |
||||||||||
|
Negative control |
5 |
2.13 |
72 |
3.17 |
15 |
1.21 |
68 |
2.01 |
7 |
2.31 |
17 |
||||||||||
|
**P-Value |
25 |
0.059 |
0.022 |
0.031 |
0.042 |
0.031 |
|||||||||||||||
|
Chitosan Film |
N |
Inflammatory cells (%) 14 days |
*p-Value |
||||||||||||||||||
|
Neutrophils |
Basophils |
Lymphocytes |
Eosinophils |
Monocytes |
|||||||||||||||||
|
SD |
Amount |
SD |
Amount |
SD |
Amount |
SD |
Amount |
SD |
Amount |
||||||||||||
|
CF10% |
5 |
0.21 |
32 |
0.17 |
2 |
1.14 |
21 |
1.06 |
1 |
0.10 |
4 |
0.001 |
|||||||||
|
CF20% |
5 |
1.03 |
29 |
0.42 |
2 |
1.67 |
19 |
1.34 |
1 |
1.72 |
3 |
||||||||||
|
CF30% |
5 |
1.25 |
25 |
0.22 |
1 |
0.17 |
15 |
1.37 |
1 |
1.16 |
2 |
||||||||||
|
CF |
5 |
0.13 |
32 |
1.05 |
2 |
0.20 |
22 |
2.01 |
1 |
1.26 |
6 |
||||||||||
|
Negative control |
5 |
1.13 |
87 |
2.07 |
17 |
1.71 |
88 |
2.71 |
9 |
1.21 |
21 |
||||||||||
|
*P-Value |
25 |
0.032 |
0.012 |
0.021 |
0.031 |
0.016 |
|||||||||||||||
* One Way Anova; CF (Chitosan film)
Table 2. Fibroblast cells in gingival tissue
|
Chitosan Film |
N |
Fibroblast cell (unit/cell) |
p-Value |
|||||||
|
7 days |
14 days |
|||||||||
|
Mean |
SD |
% |
Recovery |
Mean |
SD |
% |
Recovery |
|||
|
CF10% |
5 |
10.32 |
1.73 |
23% |
Healing process |
10.33 |
2.31 |
19% |
Medium healed |
0.001 |
|
CF20% |
5 |
10.21 |
0.00 |
23% |
Healing process |
12.78 |
0.58 |
24% |
Healed |
|
|
CF30% |
5 |
10.11 |
2.13 |
23% |
Healing process |
12.67 |
2.08 |
24% |
Healed |
|
|
CF |
5 |
9.27 |
1.14 |
21% |
Healing process |
11.23 |
0.25 |
21% |
Healed |
|
|
Negative control |
5 |
4.33 |
0.58 |
10% |
Healing process |
6.67 |
1.53 |
12% |
Not healed yet |
|
|
*p-value |
0,037 |
0,021 |
||||||||
|
0,001 |
||||||||||
* One Way ANOVA; CF (Chitosan film)
In the context of this research, the role of antioxidants contained in the combination of Chitosan and Moringa leaf extract was revealed in reducing the immune cell response during infection. Antioxidants can neutralize free radicals and reactive oxygen molecules that can form during inflammation or infection26. An excessive immune cell response can cause detrimental inflammation and damage healthy cells and tissue in infectious conditions.This study’s results indicate that using chitosan films containing antioxidants can produce a response that reduces excessive immune cell activity during infection. By reducing the exaggerated reaction of immune cells, this combination of chitosan and moringa leaf extract may help prevent unwanted inflammation and reduce cell and tissue damage that can occur during infection.
Figure 2 shows fibroblast cells on the 14th day of treatment.The number of fibroblast cells increased from day 7 and 14. It references healing in gingival trauma post-periodontal surgery (Table 2). In general, fibroblast cells are one of the critical components in the wound healing process, contributing to regeneration, scar tissue formation, and restoration of the function of damaged tissue.In addition, fibroblast cells assist in tissue remodeling during the advanced healing stage.27 The scar tissue formed initially by fibroblasts is subject to change and maturation, and the role of fibroblast cells in composing the extracellular matrix continues during this process.28. Fibroblast cells are essential in forming extracellular matrix, collagen production, and scar tissue formation in the proliferation phase of wound healing 29. The film of Chitosan has become an exciting approach to promoting wound healing by increasing fibroblast cell activity.This film can provide an optimal microenvironment for the proliferation and migration of fibroblast cells, two critical stages in wound healing.
Figure 2. Histology assessment of fibroblast cells. (A) Chitosan film10% (B) Chitosan film 20% (C) Chitosan film 30% (D) Chitosan film. 400x Magnification LED Fluorescence Microscope.
Chitosan has been known for stimulating cell growth, including fibroblast cells, which produce an extracellular matrix important in tissue regeneration30. Chitosan’s anti-inflammatory properties have also been shown to reduce inflammation around wounds, creating an environment more conducive to efficient healing31. Not only that, the hemostatic properties of chitosan play a role in controlling bleeding in wounds. At the same time, its ability to help form the extracellular matrix provides the framework needed for tissue regeneration. Fibroblast cells play a significant role in the wound-healing process.The wound healing process involves a series of complex steps, and fibroblasts are one of the cell types that play a role in the regeneration and healing of damaged tissue.32
Table 3 reports the quantity of tissue IL1-β titers after gingival trauma treatment for 14 days. The 30% film group could reduce the inflammatory response better (32.632pg/mL).At the same time, the 10% (44.329 pg/mL) and 20% (42.980pg/mL) film groups had the same ability as the chitosan film group.However, based on the quantity of IL1-β titers, these three groups were within the normal range of 32-47pg/mL compared to the negative control group (121,268pg/mL).Based on the quantity of IL1-β titers, the four treatment groups showed recovery status.While the negative control group still showed infection.The amount of IL1-β titers between the treatment groups showed significant differences (p<0.05;0.047).
Table 3. IL-1β titer in gingival tissue
|
Chitosan Film |
N |
IL-1β (pg/mL) |
p-value |
|||
|
SD |
Mean |
Freq |
Status |
|||
|
CF10% |
10 |
2.80 |
44.3298 |
15% |
Healed |
0.047 |
|
CF20% |
10 |
3.44 |
42.9808 |
15% |
Healed |
|
|
CF30% |
10 |
2.43 |
32.632 |
11% |
Healed |
|
|
CF |
10 |
2.09 |
47.8054 |
17% |
Healed |
|
|
Negative control |
10 |
3.18 |
121.268 |
42% |
Still infection |
|
* One Way Anova; CF (Chitosan Film)
The chitosan film prevents pro-inflammatory cytokine responses (Table 3).These results correlate with the immune cell response (Table 1).These findings indicate that chitosan films suppress inflammation after periodontal surgery. IL-1β is a prototypical pro-inflammatory cytokine that stimulates both local and systemic responses.However, this effect is detrimental in some circumstances, such as chronic inflammatory diseases and septic shock.The role of interleukins is to provide information to the immune system to increase its response to pathogens33. Chitosan with the compounds 2-Pentanone, 4-hydroxy-4-methyl-1,5-diphenyl- and Butane, 1,1-diethoxy-3-methyl- can effectively induce IL-1β signals to respond to inflammation.Indirectly, the involvement of chitosan in the wound-healing process significantly reduces inflammation34
Based on the findings of this study, it can be justified that the mechanism of inhibiting the release of interleukin-1 beta (IL-1β) by the antioxidant chitosan involves a series of complex interactions that lead to a reduction in the expression and release of this pro-inflammatory cytokine.This process involves several stages involving cellular activities and molecular interactions. The antioxidant chitosan inhibits the production of free radicals and oxidative stress in cells.Free radicals and oxidative stress can trigger inflammatory signaling pathways that release IL-1β35. By reducing oxidative stress, antioxidants help reduce the activation of inflammatory pathways36. Chitosan can interact with cell surface receptors involved in immune responses, such as Toll-like receptors (TLR).Chitosan binding to TLRs can inhibit the activation of signaling pathways that lead to IL-1β production.In this case, chitosan acts as a modulating agent that inhibits excessive inflammatory responses37.
Conclusions:
Conflict of Interest:
The authors declare no conflicts of interest.
Acknowledgment:
The funding for this research was provided by DRTPM Kemdikbudristek of the Indonesian Government, following the research program implementation contract for 2023, identified explicitly as No. 062/ES/PG.02.00.PL/2023.
1. Swetah VC. Oral and perioral piercings: An analysis of complications, management and use of Oral Hygiene Techniques. Research Journal of Pharmacy and Technology. 2015; 8: 1007: https://doi.org/10.5958/0974-360X.2015.00170.5
2. Stefanini M, Mounssif I, Barootchi S, et al. An exploratory clinical study evaluating safety and performance of a volume-stable collagen matrix with coronally advanced flap for single gingival recession treatment. Clinical Oral Investigations. 2020; 24: 3181-3191.https://doi.org/10.1007/s00784-019-03192-5
3. Nqakala ZB, Sibuyi NR, Fadaka AO, et al. Advances in nanotechnology towards development of silver nanoparticle-based wound-healing agents. International Journal of Molecular Sciences. 2021; 22: 11272.https://doi.org/10.3390/ijms222011272
4. Lakoh S, Yi L, Sevalie S, et al. Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: a prospective cohort study. Antimicrobial Resistance and Infection Control. 2022; 11: 1-12. https://doi.org/10.1186/s13756-022-01078-y
5. Cho Y-D, Kim K-H, Lee Y-M, et al. Periodontal wound healing and tissue regeneration: A narrative review. Pharmaceuticals. 2021; 14: 456. https://doi.org/10.3390/ph14050456
6. Abusrewil S, Alshanta OA, Albashaireh K, et al. Detection, treatment and prevention of endodontic biofilm infections: what’s new in 2020? Critical Reviews in Microbiology. 2020; 46: 194-212. https://doi.org/10.1080/1040841x.2020.1739622
7. Ramadhani P, Saputro ID, Arfiani RF, et al. Scoping review: Effects of probiotics against the immune system in burn patients. Research Journal of Pharmacy and Technology. 2023; 16: 345-353.https://doi.org/10.52711/0974-360X.2023.00061
8. Inchingolo AD, Malcangi G, Semjonova A, et al. Oralbiotica/Oralbiotics: the impact of oral microbiota on dental health and demineralization: a systematic review of the literature. Children. 2022; 9: 1014.https://doi.org/10.3390/children9071014
9. Johnson NR and Wang Y. Drug delivery systems for wound healing. Curr Pharm Biotechnol. 2015; 16: 621-629. DOI: 10.2174/1389201016666150206113720.https://doi.org/10.2174%2F1389201016666150206113720
10. Sultankulov B, Berillo D, Sultankulova K, et al. Progress in the Development of Chitosan-Based Biomaterials for Tissue Engineering and Regenerative Medicine. Biomolecules. 2019; 9 20190910. https://doi.org/10.3390/biom9090470.
11. Rajakumari K. Skin wound healing: an update on the current knowledge and concepts. Research Journal of Pharmacy and Technology. 2019; 12: 1448-1452. https://doi.org/10.5958/0974-360X.2019.00240.3
12. Bagheri M, Validi M, Gholipour A, et al. Chitosan nanofiber biocomposites for potential wound healing applications: Antioxidant activity with synergic antibacterial effect. Bioengineering and Translational Medicine. 2022; 7: e10254. https://doi.org/10.1002/btm2.10254
13. Islam MM, Shahruzzaman M, Biswas S, et al. Chitosan based bioactive materials in tissue engineering applications-A review. Bioactive Materials. 2020; 5: 164-183. https://doi.org/10.1016%2Fj.bioactmat.2020.01.012
14. Liu H, Wang C, Li C, et al. A functional chitosan-based hydrogel as a wound dressing and drug delivery system in the treatment of wound healing. RSC Advances. 2018; 8: 7533-7549. https://doi.org/10.1039%2Fc7ra13510f
15. Azmana M, Mahmood S, Hilles AR, et al. A review on chitosan and chitosan-based bionanocomposites: Promising material for combatting global issues and its applications. International Journal of Biological Macromolecules. 2021; 185: 832-848. https://doi.org/10.1016/j.ijbiomac.2021.07.023
16. Gani BA, Asmah N, Soraya C, et al. Characteristics and Antibacterial Properties of Film Membrane of Chitosan-Resveratrol for Wound Dressing. Emerging Science Journal. 2023; 7: 821-842. http://dx.doi.org/10.28991/ESJ-2023-07-03-012
17. Gani BA, Jakfar S, Nasution AI, et al. The pH stability of film membrane of nano chitosan resveratrol in various solvents. In: AIP Conference Proceedings. 2024, AIP Publishing. http://dx.doi.org/10.1063/5.0202138
18. Razdan K, Garcia-Lara J, Sinha V, et al. Pharmaceutical strategies for the treatment of bacterial biofilms in chronic wounds. Drug Discovery Today. 2022; 27: 2137-2150. https://doi.org/10.1016/j.drudis.2022.04.020
19. Xu J, Fang H, Zheng S, et al. A biological functional hybrid scaffold based on decellularized extracellular matrix/gelatin/chitosan with high biocompatibility and antibacterial activity for skin tissue engineering. International Journal of Biological Macromolecules. 2021; 187: 840-849. https://doi.org/10.1016/j.ijbiomac.2021.07.162
20. Wellington D, Mikaelian I and Singer L. Comparison of ketamine-xylazine and ketamine-dexmedetomidine anesthesia and intraperitoneal tolerance in rats. J Am Assoc Lab Anim Sci. 2013; 52: 481-487. https://pubmed.ncbi.nlm.nih.gov/23849447
21. Adewoyin AS and Nwogoh B. Peripheral blood film - a review. Ann Ib Postgrad Med. 2014; 12: 71-79. https://pubmed.ncbi.nlm.nih.gov/25960697
22. Gani BA, Nasution AI, Nazaruddin N, et al. Potential of Jatropha multifida sap against traumatic ulcer. Dental Journal (Majalah Kedokteran Gigi) 2015; 48: 119-125. https://doi.org/10.20473/j.djmkg.v48.i3.p119-125
23. Fadilah NIM, Phang SJ, Kamaruzaman N, et al. Antioxidant biomaterials in cutaneous wound healing and tissue regeneration: A critical review. Antioxidants. 2023; 12: 787. https://doi.org/10.3390/antiox12040787
24. Al-Qadsy I, Saeed WS, Al-Odayni A-B, et al. Antidiabetic, antioxidant and cytotoxicity activities of ortho-and para-substituted Schiff bases derived from metformin hydrochloride: Validation by molecular docking and in silico ADME studies. Open Chemistry. 2023; 21: 20230125. http://dx.doi.org/10.1515/chem-2023-0125
25. Hutapea AM and Lina H. Effect of hydrogen-rich water on periodontal disease, interleukin and blood glucose levels in diabetic. Journal of Syiah Kuala Dentistry Society. 2021; 6: 30-40. http://dx.doi.org/10.24815/jds.v6i1.21892
26. Menon R. Antioxidants and their therapeutic Potential-A review. Research Journal of Pharmacy and Technology. 2013; 6: 1426-1429.
27. Guillamat-Prats R. The role of MSC in wound healing, scarring and regeneration. Cells. 2021; 10: 1729. https://doi.org/10.3390/cells10071729
28. Correa‐Gallegos D, Jiang D and Rinkevich Y. Fibroblasts as confederates of the immune system. Immunological Reviews. 2021; 302: 147-162. https://doi.org/10.1111/imr.12972
29. Potekaev NN, Borzykh OB, Medvedev GV, et al. The role of extracellular matrix in skin wound healing. J Clin Med 2021; 10: 5947. https://doi.org/10.3390%2Fjcm10245947
30. Nor NAM, Halim AS and Ujang Z. Cytotoxicity Screening of Modified Chitosan Derivatives Film on Primary Human Dermal Fibroblasts. Research Journal of Pharmacy and Technology. 2015; 8: 242-250. https://doi.org/10.5958/0974-360X.2015.00041.4
31. He G, Yan X, Miao Z, et al. Anti-inflammatory catecholic chitosan hydrogel for rapid surgical trauma healing and subsequent prevention of tumor recurrence. Chinese Chemical Letters. 2020; 31: 1807-1811. https://doi.org/10.1186%2Fs12951-022-01566-8
32. Zou M-L, Teng Y-Y, Wu J-J, et al. Fibroblasts: heterogeneous cells with potential in regenerative therapy for scarless wound healing. Front Cell Dev Biol. 2021; 9: 713605. https://doi.org/10.3389%2Ffcell.2021.713605
33. Abbate A, Toldo S, Marchetti C, et al. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res. 2020; 126: 1260-1280. 20200423. https://doi.org/10.1161/circresaha.120.315937.
34. Azuma K, Izumi R, Osaki T, et al. Chitin, chitosan, and its derivatives for wound healing: old and new materials. J Funct Biomater. 2015; 6: 104-142.
35. Prabhakar O. Naringenin attenuates cerebral Ischemia-Reperfusion injury through Inhibiting oxidative stress and Inflammation in Diabetic Rats. Research Journal of Pharmacy and Technology. 2021; 14: 3751-3756. https://doi.org/10.1590%2Facb380823
36. Dutta S, Sengupta P, Slama P, et al. Oxidative stress, testicular inflammatory pathways, and male reproduction. International Journal of Molecular Sciences. 2021; 22: 10043. https://doi.org/10.3390/ijms221810043
37. Federico S, Pozzetti L, Papa A, et al. Modulation of the innate immune response by targeting toll-like receptors: a perspective on their agonists and antagonists. Journal of Medicinal Chemistry. 2020; 63: 13466-13513. https://doi.org/10.1021/acs.jmedchem.0c01049
Received on 08.11.2023 Modified on 14.03.2024
Accepted on 06.06.2024 © RJPT All right reserved
Research J. Pharm. and Tech 2024; 17(11):5305-5310.
DOI: 10.52711/0974-360X.2024.00812